Point72 Hong Kong’s RxSight RXST Stock Holding History

Point72 Hong Kong’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-684	Closed	-$33.8K	–	594
2024 Q3	$33.8K	Buy	+684	New	+$35K	﹤0.01%	391

Other funds holding RXST

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Point72 Hong Kong's RXST Position: Q4 2024 in Review

Point72 Hong Kong sold out of RxSight (RXST) in Q4 2024, closing a stake of 684 shares — an estimated $33.8K sold.

Point72 Hong Kong first reported a position in RXST in Q3 2024 and held it in 1 quarter. The position peaked at $33.8K in Q3 2024. 212 funds tracked by Wall St. Rank hold RXST as of Q4 2024.

Point72 Hong Kong reported no remaining RxSight position as of Q4 2024 after selling out during the quarter.
Point72 Hong Kong sold 684 RxSight shares in Q4 2024, an estimated $33.8K.
Point72 Hong Kong first reported a position in RxSight in Q3 2024 and held it in 1 quarter.
Point72 Hong Kong's RxSight position peaked at $33.8K in Q3 2024.
212 funds tracked by Wall St. Rank held RxSight as of Q4 2024.

Based on Point72 Hong Kong's 13F filing for Q4 2024, filed 14 Feb 2025.